Find Paid Clinical Trials in Louisiana

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Louisiana

Top of Directory » All Locations » United States » Louisiana




  • Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: MN-221 (Dose Group 1);   Drug: MN-221 (Dose Group 2);   Drug: MN-221 (Dose Group 3)
    Sponsor:   MediciNova
    Recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

    Conditions:   Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
    Interventions:   Biological: panitumumab;   Drug: paclitaxel;   Drug: carboplatin;   Procedure: laboratory biomarker analysis;   Procedure: immunohistochemistry staining method
    Sponsor:   Wake Forest University
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • EPT 100: Geranium Oil for the Relief of Neuropathic Pain

    Condition:   Neuropathic Pain
    Intervention:   Other: Geranium oil
    Sponsor:   Pennington Biomedical Research Center
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

  • Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

    Condition:   Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
    Intervention:   Device: Coaptite®
    Sponsor:   BioForm Medical, Inc.
    Recruiting - verified November 2009

  • Safety and Tolerability of TAK-491 Plus Chlorthalidone Compared to Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Essential Hypertension

    Condition:   Essential Hypertension
    Interventions:   Drug: TAK-491 and chlorthalidone;   Drug: Olmesartan medoxomil-hydrochlorothiazide
    Sponsor:   Takeda Global Research & Development Center, Inc.
    Recruiting - verified November 2009

  • A Weight Loss Study in Overweight Men and Women

    Condition:   Obesity
    Interventions:   Drug: LY377604;   Drug: Sibutramine;   Drug: Metoprolol XL;   Drug: Placebo sibutramine;   Drug: Placebo Metoprolol XL;   Drug: Placebo LY377604
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009

  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Long Term Safety and Efficacy Trial of Budesonide Dipropionate - Hydroflouroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis

    Condition:   Rhinitis, Allergic, Perennial
    Interventions:   Drug: BDP;   Drug: Placebo
    Sponsor:   Teva Global Respiratory Research LLC
    Recruiting - verified October 2009

  • Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

    Conditions:   Adnexal Mass;   Ovarian Cancer
    Intervention:  
    Sponsors:   Fujirebio Diagnostics, Inc.;   Advanced Clinical Research Services, LLC;   ReSearch Pharmaceutical Services, Inc.
    Recruiting - verified November 2009

  • NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

    Conditions:   Pain;   Back Pain;   Low Back Pain;   Back Pain With Radiation
    Interventions:   Drug: Oxycodone IR;   Drug: NUCYNTA
    Sponsors:   Ortho-McNeil Janssen Scientific Affairs, LLC;   Grünenthal
    Recruiting - verified October 2009

  • A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

    Condition:   Non-Hodgkin's Lymphoma
    Interventions:   Drug: YM155;   Biological: Rituximab
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)

    Condition:   Typical Atrial Flutter
    Intervention:   Device: Therapy Cool Path Duo
    Sponsor:   St. Jude Medical
    Recruiting - verified November 2009

  • Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

    Condition:   Influenza
    Interventions:   Drug: Oseltamivir Phosphate;   Drug: ADS-8902
    Sponsor:   Adamas Pharmaceuticals, Inc.
    Recruiting - verified September 2009

  • A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine + preprandial lispro insulin;   Biological: albiglutide + insulin glargine
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • TMC435-TiDP16-C206: A Safety and Efficacy Study in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

    Condition:   Hepatitis C
    Interventions:   Drug: TMC435 placebo /Peg IFNa2A/Ribavirin;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin
    Sponsor:   Tibotec Pharmaceuticals, Ireland
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

    Conditions:   Low Back Pain;   Low Back Pain, Recurrent
    Interventions:   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

    Conditions:   Osteoarthritis;   Osteoarthritis, Hip;   Osteoarthritis, Knee;   Pain;   Arthralgia;   Joint Pain
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis (Stabilization in Liver Disease)

    Condition:   Acute On Chronic Hepatitis
    Interventions:   Device: Extracorporeal Liver Assist Device (ELAD);   Other: Standard of care
    Sponsor:   Vital Therapies, Inc.
    Recruiting - verified October 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Placebo;   Drug: Dutogliptin
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified November 2009

  • CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: JNJ-28431754;   Drug: glimepiride
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)

    Conditions:   Pain;   Neuralgia, Postherpetic;   Neuralgia;   Mononeuropathies
    Interventions:   Drug: Placebo;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study of RO5190591 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

    Condition:   Hepatitis C, Chronic
    Interventions:   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: Placebo;   Drug: Placebo;   Drug: Pegasys;   Drug: Copegus
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

    Conditions:   Type 2 Diabetes Mellitus;   Renal Impairment
    Interventions:   Drug: dutogliptin;   Drug: dutogliptin;   Drug: placebo;   Drug: sitagliptin;   Drug: sitagliptin
    Sponsors:   Phenomix;   Forest Laboratories
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II or Stage III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Conditions:   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
    Interventions:   Biological: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds

    Conditions:   Ulcers;   Wounds
    Interventions:   Device: Traditional NPWT System;   Device: SNaP Wound Care System
    Sponsor:   Spiracur, Inc.
    Recruiting - verified October 2009

  • Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Dutogliptin;   Drug: Placebo
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified October 2009

  • Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer

    Condition:   Endometrial Cancer
    Interventions:   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

    Condition:   Asthma
    Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • Dinaciclib in Treating Patients With Stage IV Melanoma

    Condition:   Melanoma (Skin)
    Intervention:   Drug: dinaciclib
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

    Condition:   Postmenopausal Osteoporosis
    Interventions:   Drug: Ibandronate;   Drug: Denosumab
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009

  • 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

    Condition:   Schizophrenia
    Interventions:   Drug: paliperidone palmitate;   Drug: oral risperidone
    Sponsor:   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified November 2009

  • A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

    Condition:   Asthma
    Interventions:   Drug: lebrikizumab (MILR1444A);   Drug: placebo
    Sponsor:   Genentech
    Recruiting - verified October 2009

  • A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: PF-04447943;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

    Conditions:   Pain, Burning;   Pain, Crushing;   Pain, Migratory;   Pain, Radiating;   Pain, Splitting
    Interventions:   Drug: Placebo;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • 1-year Study to Assess the Efficacy, Safety and Tolerability of NVA237 in Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: NVA237;   Drug: Placebo to NVA;   Drug: Tiotropium
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

    Condition:   Overactive Bladder
    Interventions:   Drug: Fesoterodine;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials